Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 11Completed 9Recruiting 6Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Thoracic 1Other hematologic neoplasm 1Other 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Pancreatic Neoplasms 1

Interventions

Fluorouracil 51Oxaliplatin 49Gemcitabine 47Leucovorin 41Capecitabine 35Bevacizumab 29Irinotecan 25Cisplatin 22Radiotherapy 18Radiosurgery 18pembrolizumab 16Nivolumab 16Cetuximab 15Taxes 14Sorafenib 14Paclitaxel 13Biopsy 13Surgical Procedures, Operative 12Drug Therapy 11atezolizumab 10Radiation 10Albumin-Bound Paclitaxel 10lenvatinib 9durvalumab 9Magnetic Resonance Spectroscopy 9Folfox protocol 9Cyclophosphamide 9130-nm albumin-bound paclitaxel 9spartalizumab 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Practice Guidelines as Topic × Gastrointestinal × Clear all
NCT06545344 2025-06-29

Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm

Fred Hutchinson Cancer Center

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡